Serum interleukin-6 levels as an early marker of therapeutic response to UVB radiation and topical steroids in psoriatic patients.
Bonifati
C
C
Solmone
M
M
Trento
E
E
Pietravalle
M
M
Fazio
M
M
Ameglio
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001623:Betamethasone / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008875:Middle Aged; D011565:Psoriasis / Q000628:therapy*; D012459:Salicylates / Q000627:therapeutic use; D020156:Salicylic Acid; D012720:Severity of Illness Index; D014467:Ultraviolet Therapy
D015415:Biomarkers; D015850:Interleukin-6; D012459:Salicylates; D001623:Betamethasone; D020156:Salicylic Acid